| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $38.7M | — | +11.7% |
| Cost of Revenue | $15.1M | — | -1.4% |
| Gross Profit | $23.5M | — | +22.2% |
| R&D Expense | $11.3M | — | -4.8% |
| SG&A Expense | $7.3M | — | +3.6% |
| Operating Income | -$5.4M | — | +40.0% |
| Pre-tax Income | -$6.1M | — | +33.8% |
| Income Tax | $28K | — | -66.7% |
| Net Income | -$6.1M | — | +34.1% |
| EPS (Basic) | -$0.10 | — | +41.2% |
| EPS (Diluted) | -$0.10 | — | +41.2% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $26.3M | -10.0% | -35.3% |
| Short-term Investments | $19.2M | -13.5% | +52.1% |
| Accounts Receivable | $4.3M | +22.4% | +140.7% |
| Current Assets | $62.8M | -4.3% | -3.4% |
| Total Assets | $192.7M | +0.4% | +13.2% |
| Current Liabilities | $59.9M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $3.4M | — | -32.0% |
| Capital Expenditures | $651K | — | +29.4% |
| Investing Cash Flow | $289K | — | +104.7% |
| Financing Cash Flow | -$6.6M | — | -64.7% |
| Free Cash Flow | $2.7M | — | -39.0% |
| +0.8% |
| Total Liabilities | $108.0M | -0.5% | +16.9% |
| Stockholders' Equity | $84.6M | +1.7% | +8.8% |